INSPのチャート
INSPの企業情報
| symbol | INSP |
|---|---|
| 会社名 | Inspire Medical Systems Inc （INSPRE MED SYSTM） |
| 分野（sector） | |
| 産業（industry） | |
| 業種 | 医療機器_医療用品_ディストリビュ―タ― 医療関連（Health Care） |
| 概要 | Inspire Medical Systems Inc. is a medical technology company. The Company is focused on the developing and commercialization of minimally invasive solutions for patients with obstructive sleep apnea. The Company has developed a novel closed-loop solution that continuously monitors a patient's breathing patterns and delivers mild hypoglossal nerve stimulation to maintain an open airway. The system delivers mild stimulation to the hypoglossal nerve which controls the movement of user's tongue and other key airway muscles. By stimulating these muscles the airway remains open during sleep. The system is controlled by a small handheld sleep remote. インスパイア・メディカル・システムズは米国の医療機器メ―カ―。主に閉塞性睡眠時無呼吸症(OSA)の患者に対する低侵襲ソリュ―ションの開発・商品化に従事する。同社は、中程度から重度の睡眠時無呼吸症を治療するため、安全で効果的な神経刺激技術の「Inspire」システムを提供する。本社所在地はミネソタ州メ―プル・グロ―ブ。 Inspire is a medical technology company focused on the development and commercialization of innovative and minimally invasive solutions for patients with obstructive sleep apnea. Inspire's proprietary Inspire therapy is the first and only FDA-approved neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. |
| 本社所在地 | 5500 Wayzata Blvd. Suite 1600 Golden Valley MN 55416 USA |
| 代表者氏名 | Marilyn Carlson Nelson |
| 代表者役職名 | Independent Chairman of the Board |
| 電話番号 | +1 763-957-5037 |
| 設立年月日 | 39387 |
| 市場名 | NYSE（ニューヨーク証券取引所） |
| ipoyear | 年 |
| 従業員数 | － |
| url | www.inspiresleep.com |
| nasdaq_url | |
| adr_tso | |
| EBITDA | （百万ドル） -19.98500 |
| 終値（lastsale） | |
| 時価総額（marketcap） | |
| 時価総額 | （百万ドル） 1222.36900 |
| 売上高 | （百万ドル） 50.59300 |
| 企業価値(EV) | （百万ドル） 1059.08500 |
| 当期純利益 | （百万ドル） -21.82800 |
| 決算概要 | BRIEF: For the fiscal year ended 31 December 2018 Inspire Medical Systems Inc revenues increased 77% to $50.6M. Net loss increased 25% to $21.8M. Revenues reflect United States segment increase of 83% to $44.4M Europe segment increase of 45% to $6.2M. Higher net loss reflects General and administrative - Balancing v increase from $3.7M to $52.4M (expense) Interest expense increase of 88% to $3.3M (expense). |
INSPのテクニカル分析
INSPのニュース
Inspire Medical Systems, Inc. (INSP) Q3 2022 Earnings Call Transcript 2022/11/02 00:10:28 Seeking Alpha
Inspire Medical Systems, Inc. (NYSE:NYSE:INSP) Q3 2022 Earnings Conference Call November 1, 2022 05:00 PM ET Company Participants Ezgi Yagci - IR Tim Herbert - President & CEO Rick…
Inspire Medical Systems Earnings, Revenue Beat in Q3 By Investing.com 2022/11/01 23:24:00 Investing.com
Inspire Medical Systems Earnings, Revenue Beat in Q3
Inspire Medical Systems, Inc. Announces Third Quarter 2022 Financial Results and Updates 2022 Outlook 2022/11/01 20:02:00 GlobeNewswire
Inspire Reports Year-over-Year Revenue Growth of 77% in the Third Quarter Inspire Reports Year-over-Year Revenue Growth of 77% in the Third Quarter
Earnings Preview For Inspire Medical Systems 2022/10/31 17:45:18 Benzinga
Inspire Medical Systems (NYSE: INSP ) is set to give its latest quarterly earnings report on Tuesday, 2022-11-01. Here''s what investors need to know before the announcement. Analysts estimate that Inspire Medical Systems will report an earnings per share (EPS) of $-0.77. Inspire Medical Systems bulls will hope to hear the company to announce they''ve not only beaten that estimate, but also to provide positive guidance, or forecasted growth, … Full story available on Benzinga.com
Inspire Medical Systems: Sleep Apnea Equipment - Today’s Best Stock Buy 2022/10/26 19:27:01 Seeking Alpha
INSP hedging contracts costs exist because price gain expectations exist. Click here to read our analysis of the INSP stock.
Inspire Medical Systems: Sleep Apnea Value Delivery Pocket (NYSE:INSP) 2022/10/13 08:47:08 Seeking Alpha
Our selection of INSP is established by its currently-attractive stock pricing. Read why the stock appears to be a logical buy for near-term capital gain.
Inspire Medical Systems, Inc. to Report Third Quarter 2022 Financial Results on November 1, 2022 2022/10/04 12:00:00 GlobeNewswire
MINNEAPOLIS, Oct. 04, 2022 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire) will release financial results for the third quarter 2022 after the close of trading on Tuesday, November 1. Inspire’s management team will host a corresponding conference call beginning at 5:00 p.m. Eastern Time to discuss the financial results and recent business developments.
Baron Funds is Wary of Inspire Medical Systems (INSP)’s Current Valuation 2022/09/14 16:27:12 Insider Monkey
Baron Funds, an asset management company, released its “Baron Discovery Fund” second quarter 2022 investor letter. A copy of the same can be downloaded here. The fund was down 22.66% in the second quarter, 3.41% below its benchmark index, the Russell 2000 Growth Index. The firm focuses more on secular growth stories instead of cyclical […]
Inspire Medical Systems Enters Oversold Territory (INSP) 2022/09/03 09:08:39 Nasdaq
Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which m
Inspire Medical Systems, Inc. to Present at the Wells Fargo 2022 Healthcare Conference 2022/08/25 12:00:00 GlobeNewswire
MINNEAPOLIS, Aug. 25, 2022 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, announced today that its management team will present at the Wells Fargo 2022 Healthcare Conference on Thursday, September 8, 2022 at the Encore Boston Harbor in Boston, MA.
Baron Funds is Wary of Inspire Medical Systems (INSP)’s Current Valuation 2022/09/14 16:27:12 Insider Monkey
Baron Funds, an asset management company, released its “Baron Discovery Fund” second quarter 2022 investor letter. A copy of the same can be downloaded here. The fund was down 22.66% in the second quarter, 3.41% below its benchmark index, the Russell 2000 Growth Index. The firm focuses more on secular growth stories instead of cyclical […]
Inspire Medical Systems Enters Oversold Territory (INSP) 2022/09/03 09:08:39 Nasdaq
Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which m
Inspire Medical Systems, Inc. to Present at the Wells Fargo 2022 Healthcare Conference 2022/08/25 12:00:00 GlobeNewswire
MINNEAPOLIS, Aug. 25, 2022 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, announced today that its management team will present at the Wells Fargo 2022 Healthcare Conference on Thursday, September 8, 2022 at the Encore Boston Harbor in Boston, MA.
Inspire Medical Systems prices 1M of stock offering at $215.00/share 2022/08/12 08:50:22 Seeking Alpha
Inspire Medical Systems (INSP) has priced an underwritten public offering of 1M shares of its common stock, at a public offering price of $215.00/share.Underwriter are granted a…
Inspire Medical Systems, Inc. Announces Pricing of Offering of Common Stock 2022/08/12 01:41:00 GlobeNewswire
MINNEAPOLIS, Aug. 11, 2022 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (“Inspire”), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, announced today the pricing of an underwritten public offering of 1,000,000 shares of its common stock, at a public offering price of $215.00 per share, before underwriting discounts and commissions. In addition, Inspire has granted the underwriter a 30-day option to purchase up to an additional 150,000 shares of its common stock at the public offering price, less underwriting discounts and commissions, to cover sales by the underwriter in the initial offering of the shares or in the open market. All of the shares in the offering are to be sold by Inspire. The offering is expected to close on August 16, 2022, subject to customary closing conditions.